Context Therapeutics Inc. (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, will participate in several upcoming investor conferences. The company will attend the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY on February 11-12, 2026, featuring a fireside chat on February 11 at 8:30 AM ET and 1x1 meetings the same day. Context will also present at the TD Cowen 46th Annual Health Care Conference in Boston, MA, with a presentation scheduled for March 3, 2026 at 10:30 AM ET and 1x1 meetings. Additionally, the company will participate in the Citizens Life Sciences Conference in Miami, FL on March 10-11, 2026, including a fireside chat on March 10 at 11:20 AM ET and 1x1 meetings. At the Leerink Partners Global Healthcare Conference, also in Miami, a fireside chat will take place on March 11, 2026 at 9:20 AM ET, along with 1x1 meetings. A live webcast of the TD Cowen presentation and other events will be available on the News and Events section of the company's website at https://ir.contexttherapeutics.com, with replays accessible for 90 days. For additional information or to request a meeting, contact your conference representative or IR@contexttherapeutics.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9650615-en) on February 09, 2026, and is solely responsible for the information contained therein.